• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表面组成和润湿性对高载药量无定形分散体剂型溶出性能的重要性。

The importance of surface composition and wettability on the dissolution performance of high drug loading amorphous dispersion formulations.

作者信息

Hiew Tze Ning, Solomos Marina A, Kafle Prapti, Polyzois Hector, Zemlyanov Dmitry Y, Punia Ashish, Smith Daniel, Schenck Luke, Taylor Lynne S

机构信息

Department of Industrial and Molecular Pharmaceutics, College of Pharmacy, Purdue University, West Lafayette, Indiana 47907, United States.

Oral Formulation Sciences, Merck & Co., Inc., Rahway, New Jersey 07065, United States.

出版信息

J Pharm Sci. 2025 Jan;114(1):289-303. doi: 10.1016/j.xphs.2024.09.020. Epub 2024 Sep 28.

DOI:10.1016/j.xphs.2024.09.020
PMID:39349295
Abstract

One of the limitations with an amorphous solid dispersion (ASD) formulation strategy is low drug loading. Hydrophobic drugs have poor wettability and require a substantial amount of polymer to stabilize the amorphous drug and facilitate release. Using grazoprevir and hypromellose acetate succinate as model drug and polymer, respectively, the interplay between particle surface composition, particle wettability, and release performance was investigated. A hierarchical particle approach was used where the surfaces of high drug loading ASDs generated by either solvent evaporation or co-precipitation were further modified with a secondary excipient (i.e., polymer or wetting agent). The surface-modified particles were characterized for drug release, wettability, morphology, and surface composition using two-stage dissolution studies, contact angle measurements, scanning electron microscopy, and X-ray photoelectron spectroscopy, respectively. Despite surface modification with hydrophilic polymers, the hierarchical particles did not consistently exhibit good release performance. Contact angle measurements showed that the secondary excipient had a profound impact on particle wettability. Particles with good wettability showed improved drug release relative to particles that did not wet well, even with similar drug loadings. These observations underscore the intricate interplay between particle wettability and performance in amorphous dispersion formulations and illustrate a promising hierarchical particle approach to formulate high drug loading amorphous dispersions with improved dissolution performance.

摘要

无定形固体分散体(ASD)制剂策略的局限性之一是药物载量低。疏水性药物的润湿性差,需要大量聚合物来稳定无定形药物并促进释放。分别以格拉瑞韦和醋酸羟丙甲纤维素琥珀酸酯作为模型药物和聚合物,研究了颗粒表面组成、颗粒润湿性和释放性能之间的相互作用。采用了一种分级颗粒方法,通过溶剂蒸发或共沉淀生成的高载药量ASD的表面,用第二种辅料(即聚合物或润湿剂)进一步修饰。分别使用两阶段溶出研究、接触角测量、扫描电子显微镜和X射线光电子能谱对表面改性颗粒的药物释放、润湿性、形态和表面组成进行了表征。尽管用亲水性聚合物进行了表面改性,但分级颗粒并未始终表现出良好的释放性能。接触角测量表明,第二种辅料对颗粒润湿性有深远影响。润湿性良好的颗粒相对于润湿性不佳的颗粒,即使载药量相似,药物释放也有所改善。这些观察结果强调了颗粒润湿性与无定形分散体制剂性能之间的复杂相互作用,并说明了一种有前景的分级颗粒方法,用于制备具有改善溶出性能的高载药量无定形分散体。

相似文献

1
The importance of surface composition and wettability on the dissolution performance of high drug loading amorphous dispersion formulations.表面组成和润湿性对高载药量无定形分散体剂型溶出性能的重要性。
J Pharm Sci. 2025 Jan;114(1):289-303. doi: 10.1016/j.xphs.2024.09.020. Epub 2024 Sep 28.
2
Improving Dissolution Performance and Drug Loading of Amorphous Dispersions Through a Hierarchical Particle Approach.通过分级粒子方法改善无定形分散体的溶出性能和载药量。
J Pharm Sci. 2023 Aug;112(8):2057-2068. doi: 10.1016/j.xphs.2022.12.019. Epub 2022 Dec 25.
3
Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.利托那韦-共聚维酮无定形固体分散体的溶解机制研究:一致释放对于增强性能的重要性。
Mol Pharm. 2019 Mar 4;16(3):1327-1339. doi: 10.1021/acs.molpharmaceut.8b01261. Epub 2019 Feb 5.
4
Building a better particle: Leveraging physicochemical understanding of amorphous solid dispersions and a hierarchical particle approach for improved delivery at high drug loadings.构建更优颗粒:利用无定形固体分散体的物理化学理解和分级颗粒方法,提高高载药量下的递送效果。
Int J Pharm. 2019 Mar 25;559:147-155. doi: 10.1016/j.ijpharm.2019.01.009. Epub 2019 Jan 14.
5
Molecular-Level Examination of Amorphous Solid Dispersion Dissolution.非晶态固体分散体溶解的分子水平研究。
Mol Pharm. 2021 Nov 1;18(11):3999-4014. doi: 10.1021/acs.molpharmaceut.1c00289. Epub 2021 Sep 27.
6
Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.通过热熔挤出和条粒化制备双聚合物无定形固体分散体的配方性能和可加工窗口。
Int J Pharm. 2018 Dec 20;553(1-2):408-421. doi: 10.1016/j.ijpharm.2018.10.035. Epub 2018 Oct 14.
7
Congruent release of drug and polymer: A "sweet spot" in the dissolution of amorphous solid dispersions.药物和聚合物的一致释放:无定形固体分散体溶解中的“最佳点”。
J Control Release. 2019 Mar 28;298:68-82. doi: 10.1016/j.jconrel.2019.01.039. Epub 2019 Feb 4.
8
Formulating Amorphous Solid Dispersions: Impact of Inorganic Salts on Drug Release from Tablets Containing Itraconazole-HPMC Extrudate.无定形固体分散体的制定:无机盐对含伊曲康唑-HPMC 挤出物片剂中药物释放的影响。
Mol Pharm. 2020 Aug 3;17(8):2768-2778. doi: 10.1021/acs.molpharmaceut.9b01109. Epub 2020 Jul 21.
9
Drug Release and Nanodroplet Formation from Amorphous Solid Dispersions: Insight into the Roles of Drug Physicochemical Properties and Polymer Selection.从无定形固体分散体中释放药物和形成纳米液滴:深入了解药物物理化学性质和聚合物选择的作用。
Mol Pharm. 2021 May 3;18(5):2066-2081. doi: 10.1021/acs.molpharmaceut.1c00055. Epub 2021 Mar 30.
10
Congruent Release of Drug and Polymer from Amorphous Solid Dispersions: Insights into the Role of Drug-Polymer Hydrogen Bonding, Surface Crystallization, and Glass Transition.无定形固体分散体中药物和聚合物的一致释放:对药物-聚合物氢键、表面结晶和玻璃化转变作用的深入了解。
Mol Pharm. 2020 Apr 6;17(4):1261-1275. doi: 10.1021/acs.molpharmaceut.9b01272. Epub 2020 Mar 17.

引用本文的文献

1
Roles of Supersaturation and Liquid-Liquid Phase Separation for Enhanced Oral Absorption of Poorly Soluble Drugs from Amorphous Solid Dispersions.过饱和度和液-液相分离在增强难溶性药物从无定形固体分散体中的口服吸收方面的作用。
Pharmaceutics. 2025 Feb 16;17(2):262. doi: 10.3390/pharmaceutics17020262.